REGN EBITDA
Regeneron Pharmaceuticals · EBITDA
REGN EBITDA
Latest reported$5.75Bperiod ending
REGN TTM EBITDA (-$3.30M → $5.75B)
TTM EBITDA
High-resolution chart · PNG
REGN ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| 5,750,000,000 | |
| 5,744,900,000 | |
| 5,818,200,000 | |
| 5,712,300,000 | |
| 5,421,500,000 | |
| 5,527,700,000 | |
| 5,318,000,000 | |
| 5,501,900,000 | |
| 5,107,400,000 | |
| 4,548,700,000 | |
| 4,693,300,000 | |
| 4,856,600,000 | |
| 5,240,300,000 | |
| 5,086,100,000 | |
| 5,259,600,000 | |
| 6,409,400,000 | |
| 6,695,700,000 | |
| 9,483,300,000 | |
| 9,669,300,000 | |
| 8,378,400,000 | |
| 7,558,300,000 | |
| 4,707,400,000 | |
| 4,103,200,000 | |
| 3,752,900,000 | |
| 3,498,200,000 | |
| 2,795,600,000 | |
| 2,669,600,000 | |
| 2,445,108,000 | |
| 2,294,704,000 | |
| 2,706,538,000 | |
| 2,729,933,000 | |
| 2,598,934,000 | |
| 2,529,644,000 | |
| 2,399,387,000 | |
| 2,249,097,000 | |
| 2,024,215,000 | |
| 1,808,651,000 | |
| 1,558,931,000 | |
| 1,433,311,000 | |
| 1,316,876,000 | |
| 1,336,030,000 | |
| 1,379,530,000 | |
| 1,326,825,000 | |
| 1,302,771,000 | |
| 1,086,399,000 | |
| 961,664,000 | |
| 859,553,000 | |
| 852,980,000 | |
| 903,861,000 | |
| 837,198,000 | |
| 802,642,000 | |
| 735,109,000 | |
| 699,714,000 | |
| 628,351,000 | |
| 496,665,000 | |
| 304,156,000 | |
| 42,480,000 | |
| -106,335,000 | |
| -170,528,000 | |
| -138,420,000 | |
| -115,701,000 | |
| -84,074,000 | |
| -75,363,000 | |
| -104,714,000 | |
| -75,668,000 | |
| -69,144,000 | |
| -63,146,000 | |
| -54,876,000 | |
| -74,332,000 | |
| -77,742,000 | |
| -72,450,000 | |
| -55,435,000 | |
| -74,086,000 | |
| -85,138,000 | |
| -102,967,000 | |
| -124,422,000 | |
| -113,163,000 | |
| -105,992,000 | |
| -93,063,000 | |
| 160,222,000 | |
| 154,319,000 | |
| 146,542,000 | |
| 139,925,000 | |
| -75,380,000 | |
| -51,948,000 | |
| -33,563,000 | |
| 14,713,000 | |
| -6,002,000 | |
| -21,029,000 | |
| -38,010,000 | |
| -87,895,000 | |
| -107,655,000 | |
| -115,616,000 | |
| -116,406,000 | |
| -113,500,000 | |
| -108,698,000 | |
| -100,465,000 | |
| -89,409,000 | |
| -79,606,000 | |
| -60,037,000 |